拓新药业
(301089)
| 流通市值：21.37亿 | | | 总市值：30.17亿 |
| 流通股本：8964.93万 | | | 总股本：1.27亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 74,700,306.28 | 115,672,906.05 | 140,264,360.55 | 69,555,511.74 |
| 交易性金融资产 | 130,417,019.17 | 115,556,263.01 | 105,147,519.18 | 185,276,136.12 |
| 应收票据及应收账款 | 80,410,274.16 | 68,277,360.25 | 79,178,227.6 | 94,941,544.96 |
| 其中：应收票据 | 20,757,847.79 | 22,815,761.56 | 20,588,112.5 | 16,716,279.79 |
| 应收账款 | 59,652,426.37 | 45,461,598.69 | 58,590,115.1 | 78,225,265.17 |
| 应收款项融资 | 30,356,089.47 | 51,314,997.38 | 46,942,361.45 | 37,497,057.8 |
| 预付款项 | 9,383,077.53 | 8,688,040.01 | 7,394,739.87 | 8,191,633.71 |
| 其他应收款合计 | 176,218.95 | 171,120 | 57,500 | 198,300.17 |
| 存货 | 204,844,389.67 | 196,292,549.25 | 181,611,833.75 | 190,791,788.13 |
| 一年内到期的非流动资产 | 11,265.83 | 11,158.09 | 11,051.38 | 10,945.69 |
| 其他流动资产 | 25,503,437.7 | 24,423,273.36 | 24,343,481.17 | 21,930,723.14 |
| 流动资产合计 | 555,802,078.76 | 580,407,667.4 | 584,951,074.95 | 608,393,641.46 |
| 非流动资产: | | | | |
| 长期应收款 | 276,209 | 273,567.29 | 270,950.85 | 268,359.43 |
| 其他权益工具投资 | 19,703,457.49 | 19,703,457.49 | 19,703,457.49 | 17,946,587.22 |
| 固定资产 | 786,562,025.24 | 802,010,182.69 | 814,549,811.09 | 816,687,624.08 |
| 在建工程 | 49,248,393.58 | 43,968,877.08 | 44,705,317.41 | 40,221,574.6 |
| 使用权资产 | 3,032,644.43 | 3,272,063.75 | 3,511,483.07 | 3,750,902.39 |
| 无形资产 | 100,329,602.39 | 79,418,682.66 | 80,119,768.49 | 79,733,268.72 |
| 长期待摊费用 | 3,134,045.71 | 3,375,700.24 | 3,617,354.77 | 2,872,103.65 |
| 递延所得税资产 | 71,774,282.11 | 74,077,688.09 | 70,978,697.06 | 75,468,010.95 |
| 其他非流动资产 | 42,449,569.98 | 44,462,548.08 | 42,888,489.77 | 44,023,089.22 |
| 非流动资产合计 | 1,076,510,229.93 | 1,070,562,767.37 | 1,080,345,330 | 1,080,971,520.26 |
| 资产总计 | 1,632,312,308.69 | 1,650,970,434.77 | 1,665,296,404.95 | 1,689,365,161.72 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 110,236,677.45 | 109,382,513.2 | 118,014,317.62 | 103,406,292.77 |
| 其中：应付票据 | 32,111,140.01 | 33,627,946.2 | 37,966,345.48 | 30,499,546.73 |
| 应付账款 | 78,125,537.44 | 75,754,567 | 80,047,972.14 | 72,906,746.04 |
| 合同负债 | 2,771,601.18 | 5,742,209.3 | 1,694,422.74 | 2,968,011.02 |
| 应付职工薪酬 | 9,699,370.23 | 8,690,305.11 | 10,193,465.29 | 8,288,550.03 |
| 应交税费 | 2,423,218.08 | 2,400,237.21 | 3,193,140.57 | 1,995,004.95 |
| 其他应付款合计 | 4,228,058.1 | 4,114,519.36 | 4,284,462.3 | 4,111,476.69 |
| 一年内到期的非流动负债 | 1,022,436.58 | 1,019,919.66 | 1,010,165.59 | 880,568.02 |
| 其他流动负债 | 9,724,813.8 | 9,970,273.59 | 7,579,453.26 | 8,193,373.99 |
| 流动负债合计 | 140,106,175.42 | 141,319,977.43 | 145,969,427.37 | 129,843,277.47 |
| 非流动负债: | | | | |
| 租赁负债 | 2,292,163.39 | 2,262,978.44 | 2,241,333.83 | 2,339,832.99 |
| 递延收益 | 29,237,753.09 | 30,103,526.49 | 30,545,583.08 | 31,400,206.04 |
| 递延所得税负债 | 2,352,109.9 | 2,385,765.5 | 2,363,375.22 | 3,422,861.69 |
| 非流动负债合计 | 33,882,026.38 | 34,752,270.43 | 35,150,292.13 | 37,162,900.72 |
| 负债合计 | 173,988,201.8 | 176,072,247.86 | 181,119,719.5 | 167,006,178.19 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 126,544,500 | 126,544,500 | 126,544,500 | 126,544,500 |
| 资本公积 | 621,109,964.85 | 621,109,964.85 | 621,109,964.85 | 621,109,964.85 |
| 其他综合收益 | 3,527,593.12 | 3,527,593.12 | 3,527,593.12 | 2,209,940.41 |
| 专项储备 | 2,108,218.37 | 1,231,162.53 | - | - |
| 盈余公积 | 65,222,535.36 | 65,222,535.36 | 65,222,535.36 | 65,222,535.36 |
| 未分配利润 | 639,811,295.19 | 657,262,431.05 | 667,772,092.12 | 707,272,042.91 |
| 归属于母公司股东权益合计 | 1,458,324,106.89 | 1,474,898,186.91 | 1,484,176,685.45 | 1,522,358,983.53 |
| 股东权益合计 | 1,458,324,106.89 | 1,474,898,186.91 | 1,484,176,685.45 | 1,522,358,983.53 |
| 负债和股东权益合计 | 1,632,312,308.69 | 1,650,970,434.77 | 1,665,296,404.95 | 1,689,365,161.72 |
| 公告日期 | 2026-08-28 | 2026-04-28 | 2026-03-28 | 2025-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |